OWC Pharmaceutical Research Corp. (OWCP)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: May 19, 2025
OWCP Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | 2010 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '19 Sep 30, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | 2010 - 2013 |
| Cash & Equivalents | 1.47 | 3.46 | 0.97 | 0.47 | 0.36 | 1.47 | Upgrade
|
| Cash & Short-Term Investments | 1.47 | 3.46 | 0.97 | 0.47 | 0.36 | 1.47 | Upgrade
|
| Cash Growth | -65.28% | 256.75% | 105.60% | 32.23% | -75.69% | 59408.59% | Upgrade
|
| Other Receivables | - | - | - | - | - | 0.02 | Upgrade
|
| Receivables | - | - | - | - | - | 0.02 | Upgrade
|
| Prepaid Expenses | - | - | - | 0 | 0.04 | - | Upgrade
|
| Other Current Assets | 0.23 | 0.05 | 0.07 | 0.01 | 0.01 | - | Upgrade
|
| Total Current Assets | 1.7 | 3.52 | 1.05 | 0.48 | 0.41 | 1.49 | Upgrade
|
| Property, Plant & Equipment | 0.08 | 0.04 | 0.02 | 0.02 | 0.02 | 0.03 | Upgrade
|
| Total Assets | 1.77 | 3.55 | 1.06 | 0.5 | 0.43 | 1.52 | Upgrade
|
| Accounts Payable | 0.29 | 0.1 | 0.04 | 0.01 | 0.03 | 0.02 | Upgrade
|
| Accrued Expenses | - | - | - | - | - | 0.04 | Upgrade
|
| Current Unearned Revenue | - | 0.1 | 0.1 | 0.1 | 0.05 | - | Upgrade
|
| Other Current Liabilities | 0.23 | 0.24 | 0.13 | 0.04 | 0.03 | 0 | Upgrade
|
| Total Current Liabilities | 0.54 | 0.44 | 0.27 | 0.15 | 0.11 | 0.06 | Upgrade
|
| Long-Term Debt | - | - | - | 0.25 | - | - | Upgrade
|
| Other Long-Term Liabilities | 0.9 | 10.33 | - | - | - | - | Upgrade
|
| Total Liabilities | 1.47 | 10.77 | 0.27 | 0.4 | 0.11 | 0.06 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 19.68 | 18.14 | 16.17 | 11.04 | 8.53 | 8 | Upgrade
|
| Retained Earnings | -23.43 | -27.22 | -14.52 | -9.96 | -7.55 | -5.89 | Upgrade
|
| Comprehensive Income & Other | -0.25 | -0.36 | -0.86 | -0.98 | -0.66 | -0.65 | Upgrade
|
| Total Common Equity | -4.01 | -9.44 | 0.79 | 0.1 | 0.32 | 1.46 | Upgrade
|
| Shareholders' Equity | 0.31 | -7.21 | 0.79 | 0.1 | 0.32 | 1.46 | Upgrade
|
| Total Liabilities & Equity | 1.77 | 3.55 | 1.06 | 0.5 | 0.43 | 1.52 | Upgrade
|
| Total Debt | 0.05 | - | - | 0.25 | - | - | Upgrade
|
| Net Cash (Debt) | 1.42 | 3.46 | 0.97 | 0.22 | 0.36 | 1.47 | Upgrade
|
| Net Cash Growth | -66.39% | 256.75% | 336.83% | -37.76% | -75.69% | - | Upgrade
|
| Net Cash Per Share | 0.01 | 0.02 | 0.01 | 0.00 | 0.00 | 0.03 | Upgrade
|
| Filing Date Shares Outstanding | 262.33 | 175.91 | 147.76 | 139.45 | 81.46 | 78.43 | Upgrade
|
| Total Common Shares Outstanding | 244.48 | 150.21 | 147.76 | 139.45 | 81.46 | 78.43 | Upgrade
|
| Working Capital | 1.15 | 3.08 | 0.78 | 0.34 | 0.3 | 1.43 | Upgrade
|
| Book Value Per Share | -0.02 | -0.06 | 0.01 | 0.00 | 0.00 | 0.02 | Upgrade
|
| Tangible Book Value | -4.01 | -9.44 | 0.79 | 0.1 | 0.32 | 1.46 | Upgrade
|
| Tangible Book Value Per Share | -0.02 | -0.06 | 0.01 | 0.00 | 0.00 | 0.02 | Upgrade
|
| Machinery | - | 0.07 | 0.04 | 0.03 | 0.03 | 0.03 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.